Abstract
Protease inhibitors have been shown to possess anticarcinogenic properties. Two synthetic protease inhibitors, tosyl phenylethyl chloro-methyl ketone (TPCK) and tosylarginine methylester (a competitive trypsin substrate), have been demonstrated to block the formation of skin tumors promoted with TPA in mice (1). These studies were repeated using the actinomycete-derived protease inhibitor leupeptin (2), thus establishing an in vivo basis for the involvement of proteases in the mechanism of carcinogenesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W. Troll, A. Klassen, and A. Janoff, Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases. Science, 169, 1211–1213 (1970).
M. Hozumi, M. Ogawa, T. Sugimura, T. Takenchi, and H. Umezawa, Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from actinomycetes. Cancer Res. 32, 1725–1728 (1972).
J. G. Corasanti, G. H. Hobika, and G. Markus, Interference with dimethylhydrazine induction of colon tumors in mice by e-aminocaproic acid. Science, 216, 1020–1021 (1982).
W. Troll, R. Wiesner, C. J. Shellabarger, S. Holtzman, and J. P. Stone, Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis, 1, 469–472 (1980).
F. F. Becker, Inhibition of spontaneous hepatocarcinogenesis in C3H/HeN mice by Edi Pro A, an isolated soy protein. Carcinogenesis, 2, 1213–1214 (1981).
P. Correa, Epidemiological correlations between diet and cancer frequency. Cancer Res. 41, 3685–3690 (1981).
B. Armstrong and R. Doll, Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int. J. Cancer, 15. 617–631 (1975).
J. Yavelow, T. Finlay, A. R. Kennedy, and W. Troll, Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res. 43, 2454s-2459s (1983).
J. P. Quigley, Proteolytic enzymes of normal and malignant cells. In:Surfaces of Normal and Malignant Cells (R. O. Hynes, Ed.) pp. 247–285. Sussex, England: John Wiley and Sons (1979).
D. E. Mullins and S. T. Rohrlich, The role of proteinases in cellular invasiveness. Biochim. Biophys. Acta, 695, 177–214 (1983).
J. O’Donnell-Tormey and J. P. Quigley, Inhibition of plasminogen activatory release from transformed chicken fibroblasts by a protease inhibitor. Cell, 27, 85–95 (1981).
J. O’Donnell-Tormey and J. P. Quigley, Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts. Proc. Natl. Acad. Sci. USA, 80, 344–348 (1983).
J. Yavelow, M. Collins, Y. Birk, W. Troll and A. R. Kennedy, Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray-induced transformation in vitro. Proc. Natl. Acad. Sci. USA, 82, 5395–5399 (1985).
A. R. Kennedy, The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors. Carcinogenesis (Lond.), 6, 1441–1445, (1985).
M. B. Sporn and A. B. Roberts, Autocrine growth factors and cancer. Nature 313, 745–747 (1985).
L. Waxman, J. M. Fagan, K. Tanaka and A. L. Goldberg, A soluble ATP-dependent system for protein degradation from murine erythroleukemia cells. J. Biol. Chem. 260, 11994–12000(1985).
J. J. Baldassare, S. Bakshian, M. A. Knipp, and G. J. Fisher, Inhibition of fibrinogen receptor expression and serotonin release by leupeptin and antipain. J. Biol. Chem. 260. 10531–10535 (1985).
A. R. Kennedy, B. S. Radner, and H. Nagasawa, Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom’s syndrome. Proc. Natl. Acad. Sci. USA, 81 1827–1830 (1984).
A. L. Jochen and P. Berhanu, Chymotrypsin substrate analogues inhibit endocytosis of insulin and insulin receptors in adipocytes. J. Cell Biol. 103, 1807–1816 (1986).
J. Yavelow, M. Caggana, and K. A. Beck, Proteases occurring in the cell membrane: A possible cell receptor for the Bowman-Birk type of protease inhibitors. Cancer Res. 47, 1598–1601 (1987).
J. Yavelow, C. Scott, and T. C. Mayer, Fluorescent visualization of binding and internalization of the anticarcinogenic Bowman-Birk type protease inhibitors in transformed fibroblasts. Cancer Res. 47, 1602–1607 (1987).
J. P. Quigley, Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J. Cell Biol. 71, 472–486 (1976).
M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Yavelow, J., Kraft, J.H., Schepis, L. (1987). Possible Mechanisms of Action of the Anticarcinogenic Protease Inhibitors. In: Cerutti, P.A., Nygaard, O.F., Simic, M.G. (eds) Anticarcinogenesis and Radiation Protection. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6462-1_44
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6462-1_44
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6464-5
Online ISBN: 978-1-4615-6462-1
eBook Packages: Springer Book Archive